1. Home
  2. UBX vs STFS Comparison

UBX vs STFS Comparison

Compare UBX & STFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UBX
  • STFS
  • Stock Information
  • Founded
  • UBX 2009
  • STFS 2015
  • Country
  • UBX United States
  • STFS China
  • Employees
  • UBX N/A
  • STFS N/A
  • Industry
  • UBX Biotechnology: Pharmaceutical Preparations
  • STFS
  • Sector
  • UBX Health Care
  • STFS
  • Exchange
  • UBX Nasdaq
  • STFS NYSE
  • Market Cap
  • UBX 13.9M
  • STFS 16.2M
  • IPO Year
  • UBX 2018
  • STFS 2024
  • Fundamental
  • Price
  • UBX $0.78
  • STFS $1.03
  • Analyst Decision
  • UBX Strong Buy
  • STFS
  • Analyst Count
  • UBX 3
  • STFS 0
  • Target Price
  • UBX $4.67
  • STFS N/A
  • AVG Volume (30 Days)
  • UBX 609.1K
  • STFS 373.1K
  • Earning Date
  • UBX 08-05-2025
  • STFS 02-14-2025
  • Dividend Yield
  • UBX N/A
  • STFS N/A
  • EPS Growth
  • UBX N/A
  • STFS N/A
  • EPS
  • UBX N/A
  • STFS 0.01
  • Revenue
  • UBX N/A
  • STFS $16,754,197.00
  • Revenue This Year
  • UBX N/A
  • STFS N/A
  • Revenue Next Year
  • UBX N/A
  • STFS N/A
  • P/E Ratio
  • UBX N/A
  • STFS $114.40
  • Revenue Growth
  • UBX N/A
  • STFS 75.86
  • 52 Week Low
  • UBX $0.36
  • STFS $0.80
  • 52 Week High
  • UBX $3.10
  • STFS $17.91
  • Technical
  • Relative Strength Index (RSI)
  • UBX 48.12
  • STFS N/A
  • Support Level
  • UBX $0.67
  • STFS N/A
  • Resistance Level
  • UBX $0.83
  • STFS N/A
  • Average True Range (ATR)
  • UBX 0.09
  • STFS 0.00
  • MACD
  • UBX 0.01
  • STFS 0.00
  • Stochastic Oscillator
  • UBX 24.67
  • STFS 0.00

About UBX Unity Biotechnology Inc.

Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone which is produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.

About STFS STAR FASHION CULTURE HOLDINGS LIMITED

Star Fashion Culture Holdings Ltd is a content marketing solutions services provider. The company offer services focusing on marketing campaign planning and execution, offline advertising services; and online precision marketing services. The services also include marketing campaign planning and execution, events including marathons, sports events, and music festivals.

Share on Social Networks: